US Stock MarketDetailed Quotes
ALEC Alector
- 3.760
- +0.125+3.44%
Close Nov 21 16:00 ET
- 3.760
- 0.0000.00%
Post 16:20 ET
368.23MMarket Cap-2198P/E (TTM)
3.800High3.490Low789.74KVolume3.650Open3.635Pre Close2.89MTurnover0.96%Turnover RatioLossP/E (Static)97.93MShares8.90052wk High3.10P/B308.89MFloat Cap3.49052wk Low--Dividend TTM82.15MShs Float43.320Historical High--Div YieldTTM8.53%Amplitude3.490Historical Low3.656Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Alector Stock Forum
Alector Presents Baseline Characteristics for Pivotal INFRONT-3 Phase 3 Clinical Trial at the 14th International Conference on Frontotemporal Dementias (ISFTD 2024)
Alector (Nasdaq: ALEC) presented baseline characteristics for its pivotal INFRONT-3 Phase 3 clinical trial at the 14th International Conference on Frontotemporal Dementias. The trial evaluates latozinemab, a novel monoclonal antibody, for treating frontotemporal dementia with progranulin gene mutation (FTD-GR...
Alector Presents Baseline Characteristics for INVOKE-2 Phase 2 Clinical Trial of AL002 at the Alzheimer's Association International Conference® 2024 (AAIC®)
Alector presented baseline characteristics for the INVOKE-2 Phase 2 clinical trial of AL002, a TREM2 agonist, at AAIC® 2024.
The trial, involving 381 participants with early Alzheimer's disease (AD), is the first global Phase 2 study evaluating a TREM2 agonist's safety and efficacy in slowing AD progression.
Key point...
$Alector (ALEC.US)$
$PacWest Bancorp (PACW.US)$
Who will squeeze best?
All in or just a little?
$Viasat (VSAT.US)$ +5.9% (the Wall Street Journal reported that the satellite company was close to a deal to sell a military communications unit to defense contractor $L3Harris Technologies (LHX.US)$ for nearly $2 billion.)
$Myovant Sciences (MYOV.US)$ +31.3% (the biopharmaceutical company rejected a bid by its largest shareholder, Sumitovant Biopharma, to buy the shares it doesn’t already own for $22.75 per share. Myovant said...
No comment yet